Several patients in the C-SVR and C-NR groups (33% and 50% respectively) received G-CSF therapy for neutropenia at some point during IFN therapy, but subanalyses revealed that effects of this treatment were minimal (data not shown). This evidence concerns the gene CSF3 and Decreased total neutrophil count.